☆ 4.5 Letter

Detection of SARS-CoV-2 viremia before onset of COVID-19 symptoms in an allo-transplanted patient with acute leukemia

BONE MARROW TRANSPLANTATION (2021)

Journal

BONE MARROW TRANSPLANTATION

Volume 56, Issue 3, Pages 716-719

Publisher

SPRINGERNATURE

DOI: 10.1038/s41409-020-01059-y

Keywords

-

Categories

Biophysics Oncology Hematology Immunology Transplantation

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Article Medicine, General & Internal

Persistent COVID-19 Symptoms at 6 Months After Onset and the Role of Vaccination Before or After SARS-CoV-2 Infection

Stephanie A. Richard, Simon D. Pollett, Anthony C. Fries, Catherine M. Berjohn, Ryan C. Maves, Tahaniyat Lalani, Alfred G. Smith, Rupal M. Mody, Anuradha Ganesan, Rhonda E. Colombo, David A. Lindholm, Michael J. Morris, Nikhil Huprikar, Christopher J. Colombo, Cristian Madar, Milissa Jones, Derek T. Larson, Samantha E. Bazan, Katrin Mende, David Saunders, Jeffrey Livezey, Charlotte A. Lanteri, Ann I. Scher, Celia Byrne, Jennifer Rusiecki, Evan Ewers, Nusrat J. Epsi, Julia S. Rozman, Caroline English, Mark P. Simons, David R. Tribble, Brian K. Agan, Timothy H. Burgess

Summary: Understanding the factors associated with post-COVID conditions is crucial for prevention. A cohort study found that younger age, unvaccinated status, severe initial illness, and comorbidities were associated with a higher risk of persistent post-COVID symptoms. Patients with COVID-19 were also more likely to seek medical care for diabetes, pulmonary, neurological, and mental health-related issues for at least 6 months after symptom onset. These findings can inform COVID-19 vaccination policies.

JAMA NETWORK OPEN (2023)

Add to Collection

Article Psychiatry

Eating disorder symptoms among children and adolescents in Germany before and after the onset of the COVID-19 pandemic

Ann-Kathrin Napp, Anne Kaman, Michael Erhart, Joachim Westenhoefer, Ulrike Ravens-Sieberer

Summary: This study aimed to determine the differences in the prevalence of eating disorder symptoms among children and adolescents in Germany before and after the COVID-19 pandemic and identify associated factors. The results showed that 17.18% of females and 15.08% of males in the COPSY study reported eating disorder symptoms. The overall prevalence rates were lower in the COPSY sample compared to before the pandemic. Factors associated with increased odds for eating disorder symptoms in the pandemic included male gender, anxiety, and depressive symptoms.

FRONTIERS IN PSYCHIATRY (2023)

Add to Collection

Article Biochemical Research Methods

Modeling the onset of symptoms of COVID-19: Effects of SARS-CoV-2 variant

Joseph E. Larsen, Margaret Martin, John E. Martin, James Hicks, Peter E. Kuhn

Summary: Identifying the order of symptom onset of infectious diseases can help differentiate symptomatic infections earlier in a population, aiding in non-pharmaceutical interventions and reducing disease spread. A mathematical model was developed to predict the order of symptoms in COVID-19 cases in the USA and China, with findings showing differences in symptom order between the two countries possibly due to the D614G variant of the SARS-CoV-2 virus. Symptom order was found to change with viral mutations, suggesting that the D614G variant may be more transmissible due to infected individuals coughing before developing fever.

PLOS COMPUTATIONAL BIOLOGY (2021)

Add to Collection

Article Immunology

COVID-19 Symptoms and Deaths among Healthcare Workers, United States

Shao Lin, Xinlei Deng, Ian Ryan, Kai Zhang, Wangjian Zhang, Ese Oghaghare, DeeDee Bennett Gayle, Benjamin Shaw

Summary: Age, gender, and race are associated with the risk of COVID-19 death among healthcare workers. Severe clinical indicators and specific symptoms can predict COVID-19-related deaths in healthcare workers.

EMERGING INFECTIOUS DISEASES (2022)

Add to Collection

Article Immunology

Plasma SARS-CoV-2 RNA Levels as a Biomarker of Lower Respiratory Tract SARS-CoV-2 Infection in Critically Ill Patients With COVID-19

Jana L. Jacobs, Asma Naqvi, Faraaz A. Shah, Valerie F. Boltz, Mary F. Kearney, Bryan J. McVerry, Prabir Ray, Caitlin Schaefer, Meghan Fitzpatrick, Barbara Methe, Janet S. Lee, Alison Morris, John W. Mellors, Georgios D. Kitsios, William Bain

Summary: Lower respiratory tract (LRT) and plasma viral RNA (vRNA) levels are strongly correlated in mechanically ventilated COVID-19 patients. Delayed LRT vRNA clearance is observed in nonsurvivors. Plasma vRNA may serve as a practical surrogate for LRT vRNA, especially early in critical illness.

JOURNAL OF INFECTIOUS DISEASES (2022)

Add to Collection

Article Engineering, Multidisciplinary

Clinical Characteristics and Outcomes of Severe or Critical COVID-19 Patients Presenting No Respiratory Symptoms or Fever at Onset

Juanjuan Xu, Zhengrong Yin, Yu Liu, Sufei Wang, Limin Duan, Yi An, Jinshuo Fan, Tingting Liao, Yang Jin, Jianguo Chen

Summary: A study on atypical COVID-19 patients without respiratory symptoms or fever at onset shows that some of these patients had chronic diseases, presenting symptoms such as fatigue, headache, and diarrhea. Imaging examination revealed pneumonia in most cases.

ENGINEERING (2021)

Add to Collection

News Item Multidisciplinary Sciences

Had COVID but no symptoms? You might have this genetic mutation

Max Kozlov

Summary: Form of immune-system gene linked to higher susceptibility to SARS-CoV-2 infection without illness.

NATURE (2023)

Add to Collection

Article Clinical Neurology

Characteristics, onset, and evolution of neurological symptoms in patients with COVID-19

Imen Kacem, Alya Gharbi, Chahida Harizi, Emira Souissi, Mouna Safer, Amina Nasri, Hajer Letaief, Manel Akkari, Aicha Hechaichi, Saloua Mrabet, Sonia Dhaouadi, Mouna Ben Djebara, Sondes Derouiche, Amina Gargouri, Mohamed Chahed, Nissaf Ben Alaya, Riadh Gouider

Summary: Neurological symptoms in COVID-19 are common, can occur in isolation, with headache being the most prevalent symptom. Headache, when accompanied by fever, tends to be more severe and present early in the disease course.

NEUROLOGICAL SCIENCES (2021)

Add to Collection

Article Medicine, General & Internal

Neutralisation titres against SARS-CoV-2 are sustained 6 months after onset of symptoms in individuals with mild COVID-19

Alexander P. Underwood, Christina Solund, Carlota Fernandez-Antunez, Signe Lysemose Villadsen, Anni Assing Winckelmann, Signe Bollerup, Lotte S. Mikkelsen, Anna-Louise Sorensen, Shan Feng, Ulrik Fahnoe, Ria Lassauniere, Anders Fomsgaard, Santseharay Ramirez, Nina Weis, Jens Bukh

Summary: This study found that neutralizing antibodies and spike-specific IgG can persist for up to 6 months following recovery from mild COVID-19, with neutralization titers correlated to levels of IgG and IgA.

EBIOMEDICINE (2021)

Add to Collection

Article Endocrinology & Metabolism

Distinct Clinical Features of Post-COVID-19 Vaccination Early-onset Graves' Disease

Luigi di Filippo, Laura Castellino, Agnese Allora, Stefano Frara, Roberto Lanzi, Francesca Perticone, Fanny Valsecchi, Alberto Vassallo, Raffaele Giubbini, Clifford J. Rosen, Andrea Giustina

Summary: This study suggests that PoVEO GD may be a new nosologic entity representing one-third of patients evaluated for new-onset GD in our center. Distinctive features included older age at onset, higher male prevalence, and a better initial biochemical and immunologic response to treatment.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2022)

Add to Collection

Article Endocrinology & Metabolism

Thyroid Function Before, During, and After COVID-19

Bernard Khoo, Tricia Tan, Sophie A. Clarke, Edouard G. Mills, Bijal Patel, Manish Modi, Maria Phylactou, Pei Chia Eng, Layla Thurston, Emma C. Alexander, Karim Meeran, Alexander N. Comninos, Ali Abbara, Waljit S. Dhillo

Summary: Most patients with COVID-19 present with euthyroidism. Mild reductions in TSH and FT4 were observed in COVID-19 patients, consistent with a nonthyroidal illness syndrome. In survivors of COVID-19, thyroid function tests at follow-up returned to baseline.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)

Add to Collection

Review Medicine, General & Internal

The COVID-19 pandemic - How many times were we warned before

Naim Mahroum, Isa Seida, Sevval Nil Esirgun, Nicola Luigi Bragazzi

Summary: Infectious diseases can act in both predictable and unpredictable ways, leading to the emergence and reemergence of diseases. Previous research has correctly predicted the occurrence of emerging diseases, including COVID-19. Understanding past warnings and authorities' reactions and preparations is crucial for preventing and coping with future outbreaks.

EUROPEAN JOURNAL OF INTERNAL MEDICINE (2022)

Add to Collection

Article Immunology

SARS-CoV-2 Blood RNA Load Predicts Outcome in Critically Ill COVID-19 Patients

Fabian Heinrich, Michael F. Nentwich, Eric Bibiza-Freiwald, Dominik Noerz, Kevin Roedl, Martin Christner, Armin Hoffmann, Flaminia Olearo, Stefan Kluge, Martin Aepfelbacher, Dominic Wichmann, Marc Lutgehetmann, Susanne Pfefferle

Summary: The study found that in critically ill COVID-19 patients, blood SARS-CoV-2 RNA load can serve as a prognostic factor, with significantly higher levels in non-survivors upon ICU admission and a higher probability of blood RNA clearance failure. Blood RNA load represents an important independent predictor of outcome for critically ill COVID-19 patients, with a higher impact on survival compared to respiratory tract SARS-CoV-2 RNA loads.

OPEN FORUM INFECTIOUS DISEASES (2021)

Add to Collection

Article Geriatrics & Gerontology

Signs, Symptoms, and Comorbidities Associated With Onset and Prognosis of COVID-19 in a Nursing Home

Farrell A. Tobolowsky, Ana C. Bardossy, Dustin W. Currie, Noah G. Schwartz, Rachael L. T. Zacks, Eric J. Chow, Jonathan W. Dyal, Hammad Ali, Meagan Kay, Jeffrey S. Duchin, Claire Brostrom-Smith, Shauna Clark, Kaitlyn Sykes, John A. Jernigan, Margaret A. Honein, Thomas A. Clark, Nimalie D. Stone, Sujan C. Reddy, Agam K. Rao

Summary: Retrospective review of confirmed COVID-19 cases in a US skilled nursing facility showed that most infected residents presented with abnormal vital signs or changes in oxygen levels early on, highlighting the critical role of monitoring signs and symptoms for early identification of cases.

JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2021)

Add to Collection

Letter Immunology

Recurrent SARS-CoV-2 RNA Detection after COVID-19 Illness Onset during Pregnancy

Isabel Griffin, Kate R. Woodworth, Romeo R. Galang, Veronica K. Burkel, Varsha Neelam, Samantha Siebman, Jerusha Barton, Susan E. Manning, Kathryn Aveni, Nicole D. Longcore, Elizabeth M. Harvey, Van Ngo, Deborah Mbotha, Sarah Chicchelly, Mamie Lush, Valorie Eckert, Paula Dzimira, Ayomide Sokale, Miguel Valencia-Prado, Eduardo Azziz-Baumgartner, Adam MacNeil, Suzanne M. Gilboa, Van T. Tong

Summary: The Surveillance for Emerging Threats to Mothers and Babies Network conducted longitudinal surveillance of pregnant individuals in the United States with confirmed SARS-CoV-2 infection during pregnancy. Among the 6,551 infected pregnant individuals in this analysis, 142 (2.2%) tested positive for RNA >90 days and up to 416 days after infection.

EMERGING INFECTIOUS DISEASES (2022)

Add to Collection

Article Infectious Diseases

Implementing the Lolli-Method and pooled RT-qPCR testing for SARS-CoV-2 surveillance in schools: a pilot project

Alina Chloe Kretschmer, Lena Junker, Felix Dewald, Viktoria Linne, Lea Hennen, Gibran Horemheb-Rubio, Rolf Kaiser, Gertrud Steger, Alexander Joachim, Jana Schoenenkorb, Zuelfue Cem Cosgun, Neslihan Muehlhans, Eva Heger, Elena Knops, Charlotte Leisse, Barbora Kessel, Torben Heinsohn, Isti Rodiah, Berit Lange, Anne Lena Ritter, Mira Fries, Annelene Kossow, Johannes Niessen, Joerg Doetsch, Florian Klein, Jan Rybniker, Gerd Faetkenheuer, Isabelle Suarez

INFECTION (2023)

Add to Collection

Article Immunology

Rapid Selection of Sotrovimab Escape Variants in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Omicron-Infected Immunocompromised Patients

Smaranda Gliga, Nadine Luebke, Alexander Killer, Henning Gruell, Andreas Walker, Alexander T. Dilthey, Alexander Thielen, Carolin Lohr, Charlotte Flasshove, Sarah Krieg, Joanna Ventura Pereira, Tobias Paul Seraphin, Alex Zaufel, Martin Daeumer, Hans-Martin Orth, Torsten Feldt, Johannes G. Bode, Florian Klein, Joerg Timm, Tom Luedde, Bjoern-Erik Ole Jensen

Summary: Immunocompromised patients infected with Omicron variants experience prolonged viral shedding and the emergence of escape mutations after treatment with sotrovimab. Combination therapy with remdesivir significantly reduces the occurrence of escape variants.

CLINICAL INFECTIOUS DISEASES (2023)

Add to Collection

Article Oncology

A novel serum extracellular vesicle protein signature to monitor glioblastoma tumor progression

Theophilos Tzaridis, Johannes Weller, Daniel Bachurski, Farhad Shakeri, Christina Schaub, Peter Hau, Andreas Buness, Uwe Schlegel, Joachim-Peter Steinbach, Clemens Seidel, Roland Goldbrunner, Niklas Schaefer, Robert J. Wechsler-Reya, Michael Hallek, Bjoern Scheffler, Martin Glas, Lothar Haeberle, Ulrich Herrlinger, Christoph Coch, Katrin S. Reiners, Gunther Hartmann

Summary: Evaluation of serum-derived extracellular vesicles (EVs) from glioblastoma patients reveals that the upregulation of CD29, CD44, CD81, C1QA, and histone H3 in serum EVs correlates with tumor progression, suggesting their potential as biomarkers.

INTERNATIONAL JOURNAL OF CANCER (2023)

Add to Collection

Article Oncology

Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic

Volker Arndt, Daniela Doege, Stefan Froehling, Peter Albers, Hana Alguel, Ralf Bargou, Carsten Bokemeyer, Martin Bornhaeuser, Christian H. Brandts, Peter Brossart, Sara Yvonne Brucker, Tim H. Bruemmendorf, Hartmut Doehner, Norbert Gattermann, Michael Hallek, Volker Heinemann, Ulrich Keilholz, Thomas Kindler, Cornelia von Levetzow, Florian Lordick, Ulf Peter Neumann, Christoph Peters, Dirk Schadendorf, Stephan Stilgenbauer, Thomas Zander, Daniel Zips, Delia Braun, Thomas Seufferlein, Gerd Nettekoven, Michael Baumann

Summary: The capacities of German Comprehensive Cancer Centers (CCCs) in various aspects of oncology care were significantly affected during the first 2 years of the COVID-19 pandemic. Follow-up, psycho-oncologic care, and tumor surgery were particularly impacted, along with other areas of multidisciplinary oncological care. This study highlights the importance of developing strategies to prevent similar limitations in the future.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2023)

Add to Collection

Article Hematology

Characteristics and outcomes of patients undergoing high-dose chemotherapy and autologous stem cell transplantation admitted to the intensive care unit: a single-center retrospective analysis

Jorge Garcia Borrega, Boris Boell, Matthias Kochanek, Jan-Hendrik Naendrup, Florian Simon, Noelle Sieg, Michael Hallek, Peter Borchmann, Udo Holtick, Alexander Shimabukuro-Vornhagen, Dennis A. Eichenauer, Jan-Michel Heger

Summary: A retrospective analysis was conducted on patients admitted to the intensive care unit (ICU) during hospitalization for high-dose chemotherapy and autologous stem cell transplantation (ASCT). The study found that the overall outcome was favorable for these patients.

ANNALS OF HEMATOLOGY (2023)

Add to Collection

Article Oncology

Efficacy and safety of obinutuzumab combined with fludarabine and cyclophosphamide (FCG) or bendamustine (BG) in relapsed or refractory CLL patients followed by maintenance therapy with obinutuzumab for responding patients

Nadine Kutsch, Emily Eva Holmes, Sandra Robrecht, Gudrun Schueler, Ursula Vehling-Kaiser, Thomas Decker, Sigrun Mueller-Hagen, Karin Heinisch, Sebastian Boettcher, Matthias Ritgen, Karl-Anton Kreuzer, Stephan Stilgenbauer, Anna Maria Fink, Kirsten Fischer, Barbara Eichhorst, Michael Hallek, Clemens-Martin Wendtner

LEUKEMIA & LYMPHOMA (2023)

Add to Collection

Article Biophysics

CMV-IgG pre-allogeneic hematopoietic stem cell transplantation and the risk for CMV reactivation and mortality

Kirsten Alexandra Eberhardt, Verena Jung, Elena Knops, Eva Heger, Maike Wirtz, Gertrud Steger, Rolf Kaiser, Patrick Affeldt, Udo Holtick, Florian Klein, Christof Scheid, Veronica Di Cristanziano

Summary: The quantitative interpretation of pre-allo-HSCT anti-CMV IgG levels can be used as a novel parameter for identifying patients at risk for CMV reactivation and worse prognosis post-TX.

BONE MARROW TRANSPLANTATION (2023)

Add to Collection

Article Biochemistry & Molecular Biology

In-depth virological and immunological characterization of HIV-1 cure after CCR5Δ32/Δ32 allogeneic hematopoietic stem cell transplantation

Bjoern-Erik Ole Jensen, Elena Knops, Leon Cords, Nadine Luebke, Maria Salgado, Kathleen Busman-Sahay, Jacob D. D. Estes, Laura E. P. Huyveneers, Federico Perdomo-Celis, Melanie Wittner, Cristina Galvez, Christiane Mummert, Caroline Passaes, Johanna M. M. Eberhard, Carsten Muenk, Ilona Hauber, Joachim Hauber, Eva Heger, Jozefien De Clercq, Linos Vandekerckhove, Silke Bergmann, Gabor A. Dunay, Florian Klein, Dieter Haeussinger, Johannes C. C. Fischer, Kathrin Nachtkamp, Joerg Timm, Rolf Kaiser, Thomas Harrer, Tom Luedde, Monique Nijhuis, Asier Saez-Cirion, Julian Schulze zur Wiesch, Annemarie M. J. Wensing, Javier Martinez-Picado, Guido Kobbe

Summary: A 53-year-old male who received CCR5 Delta 32/Delta 32 hematopoietic stem cell transplantation for acute myeloid leukemia showed long-term remission of HIV-1. Despite sporadic traces of HIV-1 DNA, replication-competent virus was not detected in ex vivo and in vivo assays. Low levels of immune activation and declining HIV-1-specific immune responses indicated a lack of ongoing antigen production. After 4 years of treatment interruption, the absence of viral rebound and immunological correlates provide strong evidence for HIV-1 cure after CCR5 Delta 32/Delta 32 HSCT.

NATURE MEDICINE (2023)

Add to Collection

Article Medicine, General & Internal

Short- and long-term T cell and antibody responses following dexamethasone treatment in COVID-19

Charlotte Thibeault, Lara Bardtke, Kanika Vanshylla, Veronica di Cristanziano, Kirsten A. Eberhardt, Paula Stubbemann, David Hillus, Pinkus Tober-Lau, Parnika Mukherjee, Friederike Muenn, Lena J. Lippert, Elisa T. Helbig, Tilman Lingscheid, Fridolin Steinbeis, Mirja Mittermaier, Martin Witzenrath, Thomas Zoller, Florian Klein, Leif E. Sander, Florian Kurth

Summary: This study aimed to investigate the impact of dexamethasone on immune response in COVID-19 patients. Observations on immunocompetent individuals showed that severe cases treated with dexamethasone exhibited lower T cell and antibody responses in the early phase of infection, but the difference gradually diminished after 6 months and immunization. Patients with mild COVID-19 showed comparatively lower immune response, including during convalescent booster immunization.

CLINICAL MEDICINE (2023)

Add to Collection

Article Microbiology

Comparison of the Diagnostic Accuracy of Three Real-Time PCR Assays for the Detection of Arcobacter butzleri in Human Stool Samples Targeting Different Genes in a Test Comparison without a Reference Standard

Ramona Binder, Andreas Hahn, Kirsten Alexandra Eberhardt, Ralf Matthias Hagen, Holger Rohde, Ulrike Loderstaedt, Torsten Feldt, Fred Stephen Sarfo, Veronica Di Cristanziano, Sascha Kahlfuss, Hagen Frickmann, Andreas Erich Zautner

Summary: Arcobacter butzleri has potential etiological relevance for gastroenteric disorders, but standard diagnostic algorithms are not adapted for its detection and it may go undetected unless specifically addressed. In this study, three real-time PCR assays were compared for their diagnostic accuracy in detecting A. butzleri, and the prevalence of A. butzleri in the Ghanaian population was found to be 14.7%.

MICROORGANISMS (2023)

Add to Collection

Article Biochemistry & Molecular Biology

Discovery of highly neutralizing human antibodies targeting Pseudomonas aeruginosa

Alexander Simonis, Christoph Kreer, Alexandra Albus, Katharina Rox, Biao Yuan, Dmitriy Holzmann, Joana A. Wilms, Sylvia Zuber, Lisa Kottege, Sandra Winter, Meike Meyer, Kristin Schmitt, Henning Gruell, Sebastian J. Theobald, Anna-Maria Hellmann, Christina Meyer, Meryem Seda Ercanoglu, Nina Cramer, Antje Munder, Michael Hallek, Gerd Faetkenheuer, Manuel Koch, Harald Seifert, Ernst Rietschel, Thomas C. Marlovits, Silke van Koningsbruggen-Rietschel, Florian Klein, Jan Rybniker

Summary: Drug-resistant Pseudomonas aeruginosa (PA) infection poses a serious threat to human health. This study reveals that antibodies produced by chronically infected patients can neutralize PA, providing a new approach for developing anti-PA therapeutics.

CELL (2023)

Add to Collection

Letter Urology & Nephrology

Neutralizing response against SARS-CoV-2 Omicron BA.5 and XBB.1.5 in hemodialysis patients

Patrick Affeldt, Karl August Brensing, Eva Heger, Maike Wirtz, Gertrud Steger, Felix Carlo Koehler, Thomas Benzing, Dirk Stippel, Florian Klein, Christine Kurschat, Roman-Ulrich Mueller, Veronica Di Cristanziano

CLINICAL KIDNEY JOURNAL (2023)

Add to Collection

Article Oncology

Distinct Genetically Determined Origins of Myd88/BCL2-Driven Aggressive Lymphoma Rationalize Targeted Therapeutic Intervention Strategies

Ruth Fluemann, Julia Hansen, Benedikt W. Pelzer, Pascal Nieper, Tim Lohmann, Ilmars Kisis, Tobias Riet, Viktoria Kohlhas, Phuong-Hien Nguyen, Martin Peifer, Nima Abedpour, Graziella Bosco, Roman K. Thomas, Moritz Kochanek, Jacqueline Knufer, Lorenz Jonigkeit, Filippo Beleggia, Alessandra Holzem, Reinhard Buttner, Philipp Lohneis, Jorn Meinel, Monika Ortmann, Thorsten Persigehl, Michael Hallek, Dinis Pedro Calado, Markus Chmielewski, Sebastian Klein, Joachim R. Goethert, Bjoern Chapuy, Branko Zevnik, F. Thomas Wunderlich, Bastian von Tresckow, Ron D. Jachimowicz, Ari M. Melnick, Hans Christian Reinhardt, Gero Knittel

Summary: Genomic profiling identified 5 subtypes of DLBCL, including the MCD/C5 cluster with MYD88, BCL2, PRDM1, and/or SPIB aberrations. Mouse models with B cell-specific Prdm1 or Spib aberrations were generated, showing molecular features of prememory and light-zone B cells. Combined BTK/BCL2 inhibition exhibited therapeutic activity in both mouse models and relapsed/refractory DLBCL patients.

BLOOD CANCER DISCOVERY (2023)

Add to Collection

Article Immunology

Single-cell analysis of memory B cells from top neutralizers reveals multiple sites of vulnerability within HCMV Trimer and Pentamer

Matthias Zehner, Mira Alt, Artem Ashurov, Jory A. Goldsmith, Rebecca Spies, Nina Weiler, Justin Lerma, Lutz Gieselmann, Dagmar Stoehr, Henning Gruell, Eric P. Schultz, Christoph Kreer, Linda Schlachter, Hanna Janicki, Kerstin Laib Sampaio, Cora Stegmann, Michelle D. Nemetchek, Sabrina Daehling, Leon Ullrich, Ulf Dittmer, Oliver Witzke, Manuel Koch, Brent J. Ryckman, Ramin Lotfi, Jason S. McLellan, Adalbert Krawczyk, Christian Sinzger, Florian Klein

Summary: This study analyzed the human B cell response to HCMV and identified the structural basis and mechanisms of neutralizing antibodies. Highly potent antibodies were also discovered, which outperformed known antibodies in clinical trials.

IMMUNITY (2023)

Add to Collection

Article Medicine, General & Internal

Recurrent SARS-CoV-2 infections in immunodeficiency

L. Tometten, J. J. Malin, E. Pracht, P. J. Broeckelmann, C. Horn, R. Sprute, C. A. Langhorst, M. Hallek, G. Faetkenheuer, J. Rybniker

Summary: Immunodeficient patients with chronic and recurrent SARS-CoV-2 infections pose a significant health threat and present a major challenge in terms of treatment during the ongoing pandemic. Limited therapeutic options and emerging virus variants with immune escape mechanisms further complicate the medical care of these patients.

INNERE MEDIZIN (2023)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.